{
    "abstract": "Annually influenza virus infections are responsible for hospitalization and mortality, especially in high risk groups. Constant antigenic changes in seasonal influenza viruses resulted from antigenic shifts and antigenic drifts, enable emerging of novel virus subtypes that may reduce current vaccine efficacy and impose the continuous revision of vaccine component. Currently available vaccines are usually limited by their production processes in terms of rapid adaptation to new circulating subtypes in high quantities meeting the global demand. Thus, new approaches to rapidly manufacture high yields of influenza vaccines are required. New technologies to reach maximal protection with minimal vaccine doses also need to be developed.In this study, we evaluated the systemic and local immunogenicity of a new double-adjuvanted influenza vaccine administered at the site of infection, the respiratory tract. This vaccine combines a plant-produced H1N1 influenza hemagglutinin antigen (HAC1), a silica nanoparticle-based (SiO2) drug delivery system and the mucosal adjuvant candidate bis-(3',5')-cyclic dimeric guanosine monophosphate (c-di-GMP). Mice were vaccinated by intratracheal route with HAC1/SiO2 or HAC1/c-di-GMP (single-adjuvanted vaccine) or HAC1/SiO2/c-di-GMP (double-adjuvanted vaccine) and evaluated for target-specific immune responses, such as hemagglutination inhibition and hemagglutinin-specific IgG titers, as well as local antibody (IgG and IgA) titers in the bronchoalveolar lavage (BAL). Furthermore, the HAC1-specific T-cell re-stimulation potential was assessed using precision-cut lung slices (PCLS) of vaccinated mice.The double-adjuvanted vaccine induced high systemic antibody responses comparable to the systemic vaccination control. In addition, it induced local IgG and IgA responses in the BAL. Furthermore, HAC1 induced a local T-cell response demonstrated by elevated IL-2 and IFN-\u03b3 levels in PCLS of c-di-GMP-vaccinated mice upon re-stimulation.Overall, the present study showed the potential of the double-adjuvanted vaccine to induce systemic humoral immune responses in intratracheally vaccinated mice. Furthermore, it induced a strong mucosal immune response, with evidence of antigen-primed T-cells in the lung. \u00a9 2014 The Authors.",
    "author_highlights": [
        {
            "endOffset": 12104,
            "sentence": "Additive effect of two putative adjuvants regarding a systemic and local immune response.",
            "startOffset": 12015
        },
        {
            "endOffset": 12198,
            "sentence": "Local administration of the double-adjuvanted vaccine induced systemic functional antibodies.",
            "startOffset": 12105
        },
        {
            "endOffset": 12275,
            "sentence": "The double-adjuvanted vaccine induced a local IgG and IgA antibody response.",
            "startOffset": 12199
        },
        {
            "endOffset": 12355,
            "sentence": "The double-adjuvanted vaccine induced a local cellular re-call immune response.",
            "startOffset": 12276
        }
    ],
    "bib_entries": {
        "bib0005": null,
        "bib0010": {
            "authors": [
                {
                    "first": "Eric C.J.",
                    "initial": "E.C.J.",
                    "last": "Claas"
                }
            ],
            "doi": "10.1016/S0378-1135(00)00173-5",
            "firstpage": "133",
            "issn": "03781135",
            "lastpage": "139",
            "pmid": "10799785",
            "pub_year": 2000,
            "title": "Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population",
            "volume": "74"
        },
        "bib0015": {
            "authors": [
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Juno"
                },
                {
                    "first": "Keith R.",
                    "initial": "K.R.",
                    "last": "Fowke"
                },
                {
                    "first": "Yoav",
                    "initial": "Y.",
                    "last": "Keynan"
                }
            ],
            "doi": "10.1155/2012/797180",
            "issn": "17402522",
            "pmid": "22110538",
            "pub_year": 2012,
            "title": "Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses",
            "volume": "2012"
        },
        "bib0020": null,
        "bib0025": {
            "authors": [
                {
                    "first": "Izumi",
                    "initial": "I.",
                    "last": "Watanabe"
                },
                {
                    "first": "Ted M.",
                    "initial": "T.M.",
                    "last": "Ross"
                },
                {
                    "first": "Shin Ichi",
                    "initial": "S.I.",
                    "last": "Tamura"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Ichinohe"
                },
                {
                    "first": "Satoshi",
                    "initial": "S.",
                    "last": "Ito"
                },
                {
                    "first": "Hidehiro",
                    "initial": "H.",
                    "last": "Takahashi"
                },
                {
                    "first": "Hirofumi",
                    "initial": "H.",
                    "last": "Sawa"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Chiba"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Kurata"
                },
                {
                    "first": "Tetsutaro",
                    "initial": "T.",
                    "last": "Sata"
                },
                {
                    "first": "Hideki",
                    "initial": "H.",
                    "last": "Hasegawa"
                }
            ],
            "doi": "10.1016/S0264-410X(03)00510-3",
            "firstpage": "4532",
            "issn": "0264410X",
            "lastpage": "4538",
            "pmid": "14575764",
            "pub_year": 2003,
            "title": "Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin",
            "volume": "21"
        },
        "bib0030": {
            "authors": [
                {
                    "first": "Wangxue",
                    "initial": "W.",
                    "last": "Chen"
                },
                {
                    "first": "Girishchandra B.",
                    "initial": "G.B.",
                    "last": "Patel"
                },
                {
                    "first": "Hongbin",
                    "initial": "H.",
                    "last": "Yan"
                },
                {
                    "first": "Jianbing",
                    "initial": "J.",
                    "last": "Zhang"
                }
            ],
            "doi": "10.4161/hv.6.9.11561",
            "firstpage": "706",
            "issn": "15548600",
            "lastpage": "714",
            "pub_year": 2010,
            "title": "Recent advances in the development of novel mucosal adjuvants and antigen delivery systems",
            "volume": "6"
        },
        "bib0035": {
            "authors": [
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Ebensen"
                },
                {
                    "first": "Kai",
                    "initial": "K.",
                    "last": "Schulze"
                },
                {
                    "first": "Peggy",
                    "initial": "P.",
                    "last": "Riese"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Morr"
                },
                {
                    "first": "Carlos A.",
                    "initial": "C.A.",
                    "last": "Guzm\u00e1n"
                }
            ],
            "doi": "10.1128/CVI.00119-07",
            "firstpage": "952",
            "issn": "15566811",
            "lastpage": "958",
            "pmid": "17567766",
            "pub_year": 2007,
            "title": "The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant",
            "volume": "14"
        },
        "bib0040": {
            "authors": [
                {
                    "first": "Abdullah S.",
                    "initial": "A.S.",
                    "last": "Madhun"
                },
                {
                    "first": "Lars R.",
                    "initial": "L.R.",
                    "last": "Haaheim"
                },
                {
                    "first": "Jane Kristin",
                    "initial": "J.K.",
                    "last": "N\u00f8stbakken"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Ebensen"
                },
                {
                    "first": "Jessica",
                    "initial": "J.",
                    "last": "Chichester"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                },
                {
                    "first": "Carlos A.",
                    "initial": "C.A.",
                    "last": "Guzman"
                },
                {
                    "first": "Rebecca J.",
                    "initial": "R.J.",
                    "last": "Cox"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.04.094",
            "firstpage": "4973",
            "issn": "0264410X",
            "lastpage": "4982",
            "pmid": "21600260",
            "pub_year": 2011,
            "title": "Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice",
            "volume": "29"
        },
        "bib0045": {
            "authors": [
                {
                    "first": "Signe C.",
                    "initial": "S.C.",
                    "last": "Svindland"
                },
                {
                    "first": "Gabriel K.",
                    "initial": "G.K.",
                    "last": "Pedersen"
                },
                {
                    "first": "Rishi D.",
                    "initial": "R.D.",
                    "last": "Pathirana"
                },
                {
                    "first": "Geir",
                    "initial": "G.",
                    "last": "Bredholt"
                },
                {
                    "first": "Jane K.",
                    "initial": "J.K.",
                    "last": "N\u00f8stbakken"
                },
                {
                    "first": "\u00c5sne",
                    "initial": "A.",
                    "last": "Jul-Larsen"
                },
                {
                    "first": "Carlos A.",
                    "initial": "C.A.",
                    "last": "Guzm\u00e1n"
                },
                {
                    "first": "Emanuele",
                    "initial": "E.",
                    "last": "Montomoli"
                },
                {
                    "first": "Giulia",
                    "initial": "G.",
                    "last": "Lapini"
                },
                {
                    "first": "Simona",
                    "initial": "S.",
                    "last": "Piccirella"
                },
                {
                    "first": "Inderjit",
                    "initial": "I.",
                    "last": "Jabbal-Gill"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Hinchcliffe"
                },
                {
                    "first": "Rebecca J.",
                    "initial": "R.J.",
                    "last": "Cox"
                }
            ],
            "doi": "10.1111/irv.12056",
            "firstpage": "1181",
            "issn": "17502640",
            "lastpage": "1193",
            "pmid": "23170900",
            "pub_year": 2013,
            "title": "A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine",
            "volume": "7"
        },
        "bib0050": {
            "authors": [
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Mancino"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Bevillacqua"
                }
            ],
            "doi": "10.1159/000231738",
            "firstpage": "97",
            "issn": "00205915",
            "lastpage": "103",
            "pmid": "191405",
            "pub_year": 1977,
            "title": "Adjuvant effect of amorphous silica on the immune response to various antigens in guinea pigs",
            "volume": "53"
        },
        "bib0055": {
            "authors": [
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Mancino"
                },
                {
                    "first": "Z.",
                    "initial": "Z.",
                    "last": "Ovary"
                }
            ],
            "doi": "10.1159/000232443",
            "firstpage": "253",
            "issn": "10182438",
            "lastpage": "258",
            "pmid": "6243610",
            "pub_year": 1980,
            "title": "Adjuvant effects of amorphous silica and of aluminium hydroxide on IgE and IgG1 antibody production in different inbred mouse strains",
            "volume": "61"
        },
        "bib0060": {
            "authors": [
                {
                    "first": "Vanessa",
                    "initial": "V.",
                    "last": "Neuhaus"
                },
                {
                    "first": "Katharina",
                    "initial": "K.",
                    "last": "Schwarz"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Klee"
                },
                {
                    "first": "Sophie",
                    "initial": "S.",
                    "last": "Seehase"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "F\u00f6rster"
                },
                {
                    "first": "Olaf",
                    "initial": "O.",
                    "last": "Pfennig"
                },
                {
                    "first": "Danny",
                    "initial": "D.",
                    "last": "Jonigk"
                },
                {
                    "first": "Hans Gerd",
                    "initial": "H.G.",
                    "last": "Fieguth"
                },
                {
                    "first": "Wolfgang",
                    "initial": "W.",
                    "last": "Koch"
                },
                {
                    "first": "Gregor",
                    "initial": "G.",
                    "last": "Warnecke"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                },
                {
                    "first": "Katherina",
                    "initial": "K.",
                    "last": "Sewald"
                },
                {
                    "first": "Armin",
                    "initial": "A.",
                    "last": "Braun"
                }
            ],
            "doi": "10.1371/journal.pone.0071728",
            "issn": "19326203",
            "pmid": "23967238",
            "pub_year": 2013,
            "title": "Functional Testing of an Inhalable Nanoparticle Based Influenza Vaccine Using a Human Precision Cut Lung Slice Technique",
            "volume": "8"
        },
        "bib0065": {
            "authors": [
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Lars R.",
                    "initial": "L.R.",
                    "last": "Haaheim"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.1586/erv.09.3",
            "firstpage": "493",
            "issn": "14760584",
            "lastpage": "498",
            "pmid": "19348564",
            "pub_year": 2009,
            "title": "Using plant cells as influenza vaccine substrates",
            "volume": "8"
        },
        "bib0070": {
            "authors": [
                {
                    "first": "Yoko",
                    "initial": "Y.",
                    "last": "Shoji"
                },
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Jones"
                },
                {
                    "first": "Slobodanka D.",
                    "initial": "S.D.",
                    "last": "Manceva"
                },
                {
                    "first": "Emily",
                    "initial": "E.",
                    "last": "Damon"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Bi"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Farrance"
                },
                {
                    "first": "Moneim",
                    "initial": "M.",
                    "last": "Shamloul"
                },
                {
                    "first": "Natasha",
                    "initial": "N.",
                    "last": "Kushnir"
                },
                {
                    "first": "Satish",
                    "initial": "S.",
                    "last": "Sharma"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.4161/hv.7.0.14561",
            "firstpage": "41",
            "issn": "15548600",
            "lastpage": "50",
            "pmid": "21266846",
            "pub_year": 2011,
            "title": "Plant-based rapid production of recombinant subunit hemagglutinin vaccines targeting H1N1 and H5N1 influenza",
            "volume": "7"
        },
        "bib0075": {
            "authors": [
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Ebensen"
                },
                {
                    "first": "Kai",
                    "initial": "K.",
                    "last": "Schulze"
                },
                {
                    "first": "Peggy",
                    "initial": "P.",
                    "last": "Riese"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Link"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Morr"
                },
                {
                    "first": "Carlos A.",
                    "initial": "C.A.",
                    "last": "Guzm\u00e1n"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.10.033",
            "firstpage": "1464",
            "issn": "0264410X",
            "lastpage": "1469",
            "pmid": "17187906",
            "pub_year": 2007,
            "title": "The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties",
            "volume": "25"
        },
        "bib0080": {
            "authors": [
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Ross"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Mayer"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Weinhouse"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Amikam"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Huggirat"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Benziman"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "De Vroom"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Fidder"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "De Paus"
                },
                {
                    "first": "L. A.J.M.",
                    "initial": "L.A.J.M.",
                    "last": "Sliedregt"
                },
                {
                    "first": "G. A.",
                    "initial": "G.A.",
                    "last": "Van Der Marel"
                },
                {
                    "first": "J. H.",
                    "initial": "J.H.",
                    "last": "Van Boom"
                }
            ],
            "firstpage": "18933",
            "issn": "00219258",
            "lastpage": "18943",
            "pmid": "2172238",
            "pub_year": 1990,
            "title": "The cyclic diguanylic acid regulatory system of cellulose synthesis in Acetobacter xylinum. Chemical synthesis and biological activity of cyclic nucleotide dimer, trimer, and phosphothioate derivatives",
            "volume": "265"
        },
        "bib0085": {
            "authors": [
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Hobson"
                },
                {
                    "first": "R. L.",
                    "initial": "R.L.",
                    "last": "Curry"
                },
                {
                    "first": "A. S.",
                    "initial": "A.S.",
                    "last": "Beare"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Ward-Gardner"
                }
            ],
            "doi": "10.1017/S0022172400022610",
            "firstpage": "767",
            "issn": "00221724",
            "lastpage": "777",
            "pmid": "4509641",
            "pub_year": 1972,
            "title": "The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses",
            "volume": "70"
        },
        "bib0090": {
            "authors": [
                {
                    "first": "C. W.",
                    "initial": "C.W.",
                    "last": "Potter"
                },
                {
                    "first": "J. S.",
                    "initial": "J.S.",
                    "last": "Oxford"
                }
            ],
            "doi": "10.1093/oxfordjournals.bmb.a071545",
            "firstpage": "69",
            "issn": "00071420",
            "lastpage": "75",
            "pmid": "367490",
            "pub_year": 1979,
            "title": "Determinants of immunity to influenza infection in man",
            "volume": "35"
        },
        "bib0095": {
            "authors": [
                {
                    "first": "Yoko",
                    "initial": "Y.",
                    "last": "Shoji"
                },
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Farrance"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Bautista"
                },
                {
                    "first": "Hong",
                    "initial": "H.",
                    "last": "Bi"
                },
                {
                    "first": "Konstantin",
                    "initial": "K.",
                    "last": "Musiychuk"
                },
                {
                    "first": "April",
                    "initial": "A.",
                    "last": "Horsey"
                },
                {
                    "first": "Heewoo",
                    "initial": "H.",
                    "last": "Park"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Jaje"
                },
                {
                    "first": "Brian J.",
                    "initial": "B.J.",
                    "last": "Green"
                },
                {
                    "first": "Moneim",
                    "initial": "M.",
                    "last": "Shamloul"
                },
                {
                    "first": "Satish",
                    "initial": "S.",
                    "last": "Sharma"
                },
                {
                    "first": "Jessica A.",
                    "initial": "J.A.",
                    "last": "Chichester"
                },
                {
                    "first": "Vadim",
                    "initial": "V.",
                    "last": "Mett"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                }
            ],
            "doi": "10.1111/j.1750-2659.2011.00295.x",
            "firstpage": "204",
            "issn": "17502640",
            "lastpage": "210",
            "pmid": "21974811",
            "pub_year": 2012,
            "title": "A plant-based system for rapid production of influenza vaccine antigens",
            "volume": "6"
        },
        "bib0100": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Knothe"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Mutschler"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Rochlitzer"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Winkler"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Ebensen"
                },
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "Guzman"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Hohlfeld"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Braun"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Muller"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.03.068",
            "firstpage": "4249",
            "issn": "0264410X",
            "lastpage": "4255",
            "pmid": "21463684",
            "pub_year": 2011,
            "title": "The NKT cell ligand \u03b1galactosylceramide suppresses allergic airway inflammation by induction of a Th1 response",
            "volume": "29"
        },
        "bib0105": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Henjakovic"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Sewald"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Switalla"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Kaiser"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "M\u00fcller"
                },
                {
                    "first": "T. Z.",
                    "initial": "T.Z.",
                    "last": "Veres"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Martin"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Uhlig"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Krug"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Braun"
                }
            ],
            "doi": "10.1016/j.taap.2008.04.003",
            "firstpage": "68",
            "issn": "0041008X",
            "lastpage": "76",
            "pmid": "18504053",
            "pub_year": 2008,
            "title": "Ex vivo testing of immune responses in precision-cut lung slices",
            "volume": "231"
        },
        "bib0110": {
            "authors": [
                {
                    "first": "Heinz Dieter",
                    "initial": "H.D.",
                    "last": "Held"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Martin"
                },
                {
                    "first": "Stefan",
                    "initial": "S.",
                    "last": "Uhlig"
                }
            ],
            "doi": "10.1038/sj.bjp.0702394",
            "firstpage": "1191",
            "issn": "00071188",
            "lastpage": "1199",
            "pmid": "10205008",
            "pub_year": 1999,
            "title": "Characterization of airway and vascular responses in murine lungs",
            "volume": "126"
        },
        "bib0115": {
            "authors": [
                {
                    "first": "Antoine",
                    "initial": "A.",
                    "last": "Minne"
                },
                {
                    "first": "Jamila",
                    "initial": "J.",
                    "last": "Louahed"
                },
                {
                    "first": "Sybille",
                    "initial": "S.",
                    "last": "Mehauden"
                },
                {
                    "first": "Beno\u00eet",
                    "initial": "B.",
                    "last": "Baras"
                },
                {
                    "first": "Jean Christophe",
                    "initial": "J.C.",
                    "last": "Renauld"
                },
                {
                    "first": "Rita",
                    "initial": "R.",
                    "last": "Vanbever"
                }
            ],
            "doi": "10.1111/j.1365-2567.2007.02641.x",
            "firstpage": "316",
            "issn": "00192805",
            "lastpage": "325",
            "pmid": "17521369",
            "pub_year": 2007,
            "title": "The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response",
            "volume": "122"
        },
        "bib0120": {
            "authors": [
                {
                    "first": "Per",
                    "initial": "P.",
                    "last": "Brandtzaeg"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.12.001",
            "firstpage": "5467",
            "issn": "0264410X",
            "lastpage": "5484",
            "pmid": "17227687",
            "pub_year": 2007,
            "title": "Induction of secretory immunity and memory at mucosal surfaces",
            "volume": "25"
        },
        "bib0125": {
            "authors": [
                {
                    "first": "Elly",
                    "initial": "E.",
                    "last": "van Riet"
                },
                {
                    "first": "Akira",
                    "initial": "A.",
                    "last": "Ainai"
                },
                {
                    "first": "Tadaki",
                    "initial": "T.",
                    "last": "Suzuki"
                },
                {
                    "first": "Hideki",
                    "initial": "H.",
                    "last": "Hasegawa"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.04.109",
            "firstpage": "5893",
            "issn": "0264410X",
            "lastpage": "5900",
            "pmid": "22835738",
            "pub_year": 2012,
            "title": "Mucosal IgA responses in influenza virus infections; thoughts for vaccine design",
            "volume": "30"
        },
        "bib0130": {
            "authors": [
                {
                    "first": "Yasuko",
                    "initial": "Y.",
                    "last": "Asahi"
                },
                {
                    "first": "Tomoki",
                    "initial": "T.",
                    "last": "Yoshikawa"
                },
                {
                    "first": "Izumi",
                    "initial": "I.",
                    "last": "Watanabe"
                },
                {
                    "first": "Takuya",
                    "initial": "T.",
                    "last": "Iwasaki"
                },
                {
                    "first": "Hideki",
                    "initial": "H.",
                    "last": "Hasegawa"
                },
                {
                    "first": "Yuko",
                    "initial": "Y.",
                    "last": "Sato"
                },
                {
                    "first": "Shin Ichiro",
                    "initial": "S.I.",
                    "last": "Shimada"
                },
                {
                    "first": "Masanobu",
                    "initial": "M.",
                    "last": "Nanno"
                },
                {
                    "first": "Yoshiaki",
                    "initial": "Y.",
                    "last": "Matsuoka"
                },
                {
                    "first": "Makoto",
                    "initial": "M.",
                    "last": "Ohwaki"
                },
                {
                    "first": "Yoichiro",
                    "initial": "Y.",
                    "last": "Iwakura"
                },
                {
                    "first": "Yujiro",
                    "initial": "Y.",
                    "last": "Suzuki"
                },
                {
                    "first": "Chikara",
                    "initial": "C.",
                    "last": "Aizawa"
                },
                {
                    "first": "Tetutaro",
                    "initial": "T.",
                    "last": "Sata"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Kurata"
                },
                {
                    "first": "Shin Ichi",
                    "initial": "S.I.",
                    "last": "Tamura"
                }
            ],
            "doi": "10.4049/jimmunol.168.6.2930",
            "firstpage": "2930",
            "issn": "00221767",
            "lastpage": "2938",
            "pmid": "11884464",
            "pub_year": 2002,
            "title": "Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines",
            "volume": "168"
        },
        "bib0135": {
            "authors": [
                {
                    "first": "Shin\u2010Ichi \u2010I",
                    "initial": "S.\u2010.",
                    "last": "Tamura"
                },
                {
                    "first": "Hirono",
                    "initial": "H.",
                    "last": "Funato"
                },
                {
                    "first": "Yoshihiro",
                    "initial": "Y.",
                    "last": "Hirabayashi"
                },
                {
                    "first": "Vujiro",
                    "initial": "V.",
                    "last": "Suzuki"
                },
                {
                    "first": "Takashi",
                    "initial": "T.",
                    "last": "Nagamine"
                },
                {
                    "first": "Chikara",
                    "initial": "C.",
                    "last": "Aizawa"
                },
                {
                    "first": "Takeshi",
                    "initial": "T.",
                    "last": "Kurata"
                }
            ],
            "doi": "10.1002/eji.1830210602",
            "firstpage": "1337",
            "issn": "00142980",
            "lastpage": "1344",
            "pmid": "1646112",
            "pub_year": 1991,
            "title": "Cross\u2010protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules",
            "volume": "21"
        },
        "bib0140": {
            "authors": [
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Bungener"
                },
                {
                    "first": "Felix",
                    "initial": "F.",
                    "last": "Geeraedts"
                },
                {
                    "first": "Wouter",
                    "initial": "W.",
                    "last": "ter Veer"
                },
                {
                    "first": "Jeroen",
                    "initial": "J.",
                    "last": "Medema"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Wilschut"
                },
                {
                    "first": "Anke",
                    "initial": "A.",
                    "last": "Huckriede"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.02.063",
            "firstpage": "2350",
            "issn": "0264410X",
            "lastpage": "2359",
            "pmid": "18400340",
            "pub_year": 2008,
            "title": "Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection",
            "volume": "26"
        },
        "bib0145": {
            "authors": [
                {
                    "first": "Heng",
                    "initial": "H.",
                    "last": "Liu"
                },
                {
                    "first": "Harshad P.",
                    "initial": "H.P.",
                    "last": "Patil"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "de Vries-Idema"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Wilschut"
                },
                {
                    "first": "Anke",
                    "initial": "A.",
                    "last": "Huckriede"
                }
            ],
            "doi": "10.1371/journal.pone.0069649",
            "issn": "19326203",
            "pmid": "23936066",
            "pub_year": 2013,
            "title": "Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100- Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies",
            "volume": "8"
        },
        "bib0150": {
            "authors": [
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Plante"
                },
                {
                    "first": "Taff",
                    "initial": "T.",
                    "last": "Jones"
                },
                {
                    "first": "Francine",
                    "initial": "F.",
                    "last": "Allard"
                },
                {
                    "first": "Krikor",
                    "initial": "K.",
                    "last": "Torossian"
                },
                {
                    "first": "Joelle",
                    "initial": "J.",
                    "last": "Gauthier"
                },
                {
                    "first": "Noutcheka",
                    "initial": "N.",
                    "last": "St-F\u00e9lix"
                },
                {
                    "first": "Greg L.",
                    "initial": "G.L.",
                    "last": "White"
                },
                {
                    "first": "George H.",
                    "initial": "G.H.",
                    "last": "Lowell"
                },
                {
                    "first": "David S.",
                    "initial": "D.S.",
                    "last": "Burt"
                }
            ],
            "doi": "10.1016/S0264-410X(01)00268-7",
            "firstpage": "218",
            "issn": "0264410X",
            "lastpage": "225",
            "pmid": "11567767",
            "pub_year": 2001,
            "title": "Nasal immunization with subunit proteosome influenza vaccines induces serum HAI, mucosal IgA and protection against influenza challenge",
            "volume": "20"
        },
        "bib0155": {
            "authors": [
                {
                    "first": "Rahul",
                    "initial": "R.",
                    "last": "Purwar"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Campbell"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Murphy"
                },
                {
                    "first": "William G.",
                    "initial": "W.G.",
                    "last": "Richards"
                },
                {
                    "first": "Rachael A.",
                    "initial": "R.A.",
                    "last": "Clark"
                },
                {
                    "first": "Thomas S.",
                    "initial": "T.S.",
                    "last": "Kupper"
                }
            ],
            "doi": "10.1371/journal.pone.0016245",
            "issn": "19326203",
            "pmid": "21298112",
            "pub_year": 2011,
            "title": "Resident Memory T cells (TRM) are abundant in human lung: Diversity, function, and antigen specificity",
            "volume": "6"
        },
        "bib0160": {
            "authors": [
                {
                    "first": "Asne",
                    "initial": "A.",
                    "last": "Jul-Larsen"
                },
                {
                    "first": "Abdullah S.",
                    "initial": "A.S.",
                    "last": "Madhun"
                },
                {
                    "first": "Karl A.",
                    "initial": "K.A.",
                    "last": "Brokstad"
                },
                {
                    "first": "Emanuele",
                    "initial": "E.",
                    "last": "Montomoli"
                },
                {
                    "first": "Vidadi",
                    "initial": "V.",
                    "last": "Yusibov"
                },
                {
                    "first": "Rebecca J.",
                    "initial": "R.J.",
                    "last": "Cox"
                }
            ],
            "doi": "10.4161/hv.19503",
            "firstpage": "653",
            "issn": "2164554X",
            "lastpage": "661",
            "pmid": "22634440",
            "pub_year": 2012,
            "title": "The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants",
            "volume": "8"
        },
        "bib0165": {
            "authors": [
                {
                    "first": "Wangxue",
                    "initial": "W.",
                    "last": "Chen"
                },
                {
                    "first": "Rhonda",
                    "initial": "R.",
                    "last": "KuoLee"
                },
                {
                    "first": "Hongbin",
                    "initial": "H.",
                    "last": "Yan"
                }
            ],
            "doi": "10.1016/j.vaccine.2010.02.081",
            "firstpage": "3080",
            "issn": "0264410X",
            "lastpage": "3085",
            "pmid": "20197136",
            "pub_year": 2010,
            "title": "The potential of 3\u2032,5\u2032-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant",
            "volume": "28"
        },
        "bib0170": {
            "authors": [
                {
                    "first": "Jie",
                    "initial": "J.",
                    "last": "Sun"
                },
                {
                    "first": "Rajat",
                    "initial": "R.",
                    "last": "Madan"
                },
                {
                    "first": "Christopher L.",
                    "initial": "C.L.",
                    "last": "Karp"
                },
                {
                    "first": "Thomas J.",
                    "initial": "T.J.",
                    "last": "Braciale"
                }
            ],
            "doi": "10.1038/nm.1929",
            "firstpage": "277",
            "issn": "10788956",
            "lastpage": "284",
            "pmid": "19234462",
            "pub_year": 2009,
            "title": "Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10",
            "volume": "15"
        }
    },
    "body_text": [
        {
            "endOffset": 28718,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Additionally, doubling the antigen dose increased IgG by 4.3-fold (Fig. 3A).",
            "startOffset": 28642,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 33111,
            "parents": [],
            "secId": "sec0090",
            "sentence": "At a first view, systemic vaccination seemed to be more effective than local vaccination regarding the antigen dose required to induce systemic HAI and IgG titers.",
            "startOffset": 32948,
            "title": "Discussion"
        },
        {
            "endOffset": 15182,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Therefore, there is a need of developing novel and effective influenza vaccines.",
            "startOffset": 15102,
            "title": "Introduction"
        },
        {
            "endOffset": 19322,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Phosphate buffered saline (PBS) without Ca2+ and Mg2+, pH 7.4, Dulbecco's Modified Eagle's Medium/Nutrient Mixture F-12 HAM (DMEM) with l-glutamine, 15 mM HEPES and 7.5% w/v sodium bicarbonate without phenol red, pH 7.2\u20137.4, RPMI 1640 and Earle's Balanced Salt Solution (EBSS) were obtained from Gibco (Darmstadt, Germany).",
            "startOffset": 18999,
            "title": "Media"
        },
        {
            "endOffset": 15299,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Traditionally, only systemic administration of inactivated influenza vaccines, mostly intramuscularly, has been used.",
            "startOffset": 15182,
            "title": "Introduction"
        },
        {
            "endOffset": 16294,
            "parents": [],
            "refoffsets": {
                "bib0040": {
                    "endOffset": 16293,
                    "startOffset": 16290
                }
            },
            "secId": "sec0005",
            "sentence": "Madhun et al. showed that c-di-GMP improved the immunogenicity of an intranasally delivered subunit influenza vaccine, compared to antigen only, by inducing strong mucosal and systemic immune responses [8].",
            "startOffset": 16088,
            "title": "Introduction"
        },
        {
            "endOffset": 29464,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "The positive control mice, however, secreted low levels of IL-2 compared with non-stimulated samples (fold induction 37 \u00b1 35) but showed no increase in IFN-\u03b3 production (27 \u00b1 27).",
            "startOffset": 29285,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 26777,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Results showed no detectable antigen-induced proliferation of splenocytes in the non-adjuvanted, positive control, or the HAC1/SiO2 groups (HAC1: 1.2 \u00b1 0.1; HAC1-Alum: 1.5 \u00b1 0.2; HAC1/SiO2: 1.2 \u00b1 0.2).",
            "startOffset": 26576,
            "title": "Addition of c-di-GMP adjuvant was necessary to induce antigen-specific splenocytes"
        },
        {
            "endOffset": 25674,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "On the contrary, administration of HAC1 intraperitoneally with Alum served as a positive control and induced very robust HAI (4096 \u00b1 627.1; Fig. 1A) and IgG (286,720 \u00b1 75,248; Fig. 1B) antibody titers after the second vaccination (day 35).",
            "startOffset": 25435,
            "title": "Intratracheal administration of double-adjuvanted HAC1 with SiO2 and c-di-GMP induced robust systemic antibody responses"
        },
        {
            "endOffset": 34179,
            "parents": [],
            "secId": "sec0090",
            "sentence": "New insights into immune protection have altered second generation influenza vaccines from being designed to induce systemic IgG toward the induction of broader cross-protective responses against the virus, including other antibody isotypes, such as IgA.",
            "startOffset": 33925,
            "title": "Discussion"
        },
        {
            "endOffset": 32477,
            "parents": [],
            "refoffsets": {
                "bib0045": {
                    "endOffset": 32476,
                    "startOffset": 32473
                }
            },
            "secId": "sec0090",
            "sentence": "These increased antigen-specific immune responses demonstrated the synergistic effect of the combination of nontoxic concentrations of SiO2 and c-di-GMP and were in line with the work of Svindland et al. [9].",
            "startOffset": 32269,
            "title": "Discussion"
        },
        {
            "endOffset": 22503,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Briefly, ELISA plates were coated with inactivated A/California/07/09 virus and samples of BAL or serum were tested in series of two- or four-fold dilutions.",
            "startOffset": 22346,
            "title": "Antibody measurement"
        },
        {
            "endOffset": 26481,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Splenocytes isolated from immunized mice were re-stimulated in vitro with HAC1 followed by 3H-thymidine labeling.",
            "startOffset": 26368,
            "title": "Addition of c-di-GMP adjuvant was necessary to induce antigen-specific splenocytes"
        },
        {
            "endOffset": 28506,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "HAC1/c-di-GMP induced elevated titers of mucosal IgG (135 \u00b1 68) and IgA (385 \u00b1 172) with positive titers in 80% of the vaccinated mice.",
            "startOffset": 28371,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 37864,
            "parents": [],
            "refoffsets": {
                "bib0170": {
                    "endOffset": 37863,
                    "startOffset": 37859
                }
            },
            "secId": "sec0090",
            "sentence": "Among other cytokines, IL-10 can be released by influenza-specific CD4+ memory T-cells and has been described as having a putatively crucial role in regulating inflammation during acute influenza infection [34].",
            "startOffset": 37653,
            "title": "Discussion"
        },
        {
            "endOffset": 16555,
            "parents": [],
            "refoffsets": {
                "bib0040": {
                    "endOffset": 16554,
                    "startOffset": 16551
                }
            },
            "secId": "sec0005",
            "sentence": "Additionally, the authors showed that intranasal administration of the c-di-GMP adjuvanted antigen induced protective antibody titers and cellular immune responses that far exceeded the responses induced by intramuscular administration of the same vaccine [8].",
            "startOffset": 16295,
            "title": "Introduction"
        },
        {
            "endOffset": 27053,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "In contrast, in the single-adjuvanted group (HAC1/c-di-GMP) the level of proliferation was two-fold compared to non-stimulated splenocytes (2.2 \u00b1 0.4) and the double-adjuvanted vaccine induced the highest level of splenocyte proliferation (4.4 \u00b1 1.7) upon HAC1 re-stimulation.",
            "startOffset": 26777,
            "title": "Addition of c-di-GMP adjuvant was necessary to induce antigen-specific splenocytes"
        },
        {
            "endOffset": 29965,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "No induction of IL-5 secretion was detected in the non-adjuvanted, positive control or HAC1/SiO2 vaccinated groups upon antigenic re-stimulation (fold induction \u2264 2; Fig. 4C).",
            "startOffset": 29790,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 35845,
            "parents": [],
            "refoffsets": {
                "bib0145": {
                    "endOffset": 35844,
                    "startOffset": 35840
                }
            },
            "secId": "sec0090",
            "sentence": "Of note, the challenge study performed by Liu et al. demonstrated that the immune responses induced by the adjuvanted intrapulmonary vaccination were sufficient to protect against influenza virus infection and reduce the virus titers in the lung post infection to levels below detection [29].",
            "startOffset": 35553,
            "title": "Discussion"
        },
        {
            "endOffset": 20470,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Lyophilized c-di-GMP was stored at \u221220 \u00b0C.",
            "startOffset": 20428,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 35552,
            "parents": [],
            "refoffsets": {
                "bib0145": {
                    "endOffset": 35551,
                    "startOffset": 35547
                }
            },
            "secId": "sec0090",
            "sentence": "Furthermore, they observed the highest nasal and lung IgG titers in mice primed (and boosted) via the mucosal route [29].",
            "startOffset": 35431,
            "title": "Discussion"
        },
        {
            "endOffset": 21990,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 21989,
                    "startOffset": 21985
                }
            },
            "secId": "sec0035",
            "sentence": "HAI assay was performed using 0.75% turkey erythrocytes and A/California/07/09 \u00d7 179A virus (CDC #2009713114) with an initial serum dilution of 1:20 as described previously [14].",
            "startOffset": 21812,
            "title": "HAI assay"
        },
        {
            "endOffset": 19423,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Cell/tissue cultivation medium was supplemented with 100 U/mL penicillin and 100 \u03bcg/mL streptomycin.",
            "startOffset": 19323,
            "title": "Media"
        },
        {
            "endOffset": 30881,
            "parents": [],
            "secId": "sec0090",
            "sentence": "The vaccine is intended to be used as an inhalable needle-free vaccine targeting the upper and lower respiratory tract.",
            "startOffset": 30762,
            "title": "Discussion"
        },
        {
            "endOffset": 15101,
            "parents": [],
            "refoffsets": {
                "bib0010": {
                    "endOffset": 15100,
                    "startOffset": 15095
                },
                "bib0015": {
                    "endOffset": 15100,
                    "startOffset": 15095
                }
            },
            "secId": "sec0005",
            "sentence": "The high mutational rate of the virus and frequency of interspecies transmission and/or zoonosis leading to new virus subtypes makes influenza infections highly unpredictable [2,3].",
            "startOffset": 14920,
            "title": "Introduction"
        },
        {
            "endOffset": 17747,
            "parents": [],
            "secId": "sec0005",
            "sentence": "This bottleneck of egg-produced vaccines can have serious consequences during influenza pandemics, when the production of sufficient amounts of vaccine in an adequate time frame to serve the global market could be difficult.",
            "startOffset": 17523,
            "title": "Introduction"
        },
        {
            "endOffset": 28220,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "The non-adjuvanted group (10 \u03bcg HAC1) showed no increased local IgG or IgA titers (Fig. 3A and B).",
            "startOffset": 28122,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 37240,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Yet, our study also showed a mild induction of the Th2 cytokine IL-5 and the anti-inflammatory cytokine IL-10 in re-stimulated PCLS of intratracheally c-di-GMP-vaccinated mice.",
            "startOffset": 37064,
            "title": "Discussion"
        },
        {
            "endOffset": 33204,
            "parents": [],
            "secId": "sec0090",
            "sentence": "On the contrary, 1 \u03bcg HAC1 given systemically was not sufficient to induce local IgA titers.",
            "startOffset": 33112,
            "title": "Discussion"
        },
        {
            "endOffset": 36523,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Consistent with the cytokine profile of influenza-specific multifunctional Th1 cells, our study showed increased IL-2 and IFN-\u03b3 levels in antigen re-stimulated PCLS of mice vaccinated with HAC1/c-di-GMP.",
            "startOffset": 36320,
            "title": "Discussion"
        },
        {
            "endOffset": 15950,
            "parents": [],
            "refoffsets": {
                "bib0030": {
                    "endOffset": 15948,
                    "startOffset": 15945
                }
            },
            "secId": "sec0005",
            "sentence": "Thus, many new effective mucosal adjuvants are in preclinical development (s. review [6]).",
            "startOffset": 15860,
            "title": "Introduction"
        },
        {
            "endOffset": 18998,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Reagents were, if not stated otherwise, purchased from Sigma\u2013Aldrich (Munich, Germany).",
            "startOffset": 18911,
            "title": "Media"
        },
        {
            "endOffset": 23377,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "Cells were pulsed with 5 \u03bcCi/mL 3H-thymidine (Amersham Buchler, Braunschweig, Germany) for 18 h and harvested on filter mats (Canberra-Packard, Dreieich, Germany).",
            "startOffset": 23214,
            "title": "Splenocyte proliferation assay"
        },
        {
            "endOffset": 28974,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "To determine the local antigen-specific T-cell-mediated immune response at the cytokine level, PCLS from vaccinated mice were re-stimulated with HAC1.",
            "startOffset": 28824,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 19704,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Briefly, the HA nucleotide sequence, encompassing amino acids 18\u2013530 of the A/California/04/09 influenza strain (H1N1, NCBI accession number ACQ76318.1) were optimized for expression in plants and synthesized.",
            "startOffset": 19495,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 19926,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "This gene was inserted into the pGRD4 launch vector and transformed into Agrobacterium tumefaciens.",
            "startOffset": 19827,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 29284,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "The non-adjuvanted group (HAC1 only) showed no altered IL-2 or IFN-\u03b3 expression upon antigen-stimulation compared to non-stimulated PCLS (fold induction \u2264 2; Fig. 4A and B).",
            "startOffset": 29111,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 22905,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Endpoint titers were determined as reciprocal serum dilutions that gave mean optical density (OD) values three times greater than those from pre-immune sera at a 1:100 or 1:50 dilution for IgG and IgA, respectively.",
            "startOffset": 22690,
            "title": "Antibody measurement"
        },
        {
            "endOffset": 32847,
            "parents": [],
            "secId": "sec0090",
            "sentence": "With regard to the shortage of vaccine supply during influenza pandemics and the focus of new vaccine strategies on antigen dose-sparing formulations, the double-adjuvanted vaccine showed promising results as it provided a dose sparing effect.",
            "startOffset": 32604,
            "title": "Discussion"
        },
        {
            "endOffset": 30401,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "The release of the anti-inflammatory cytokine IL-10 was at baseline levels in PCLS from the non-adjuvanted and positive control groups (fold induction \u2264 2; Fig. 4D) as well as HAC1/SiO2 immunized mice.",
            "startOffset": 30200,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 18903,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "33.9-42502-04-11/0465) and conducted according to the German Animal Protection law.",
            "startOffset": 18820,
            "title": "Animals"
        },
        {
            "endOffset": 31118,
            "parents": [],
            "secId": "sec0090",
            "sentence": "However, for the work described here, we administered the vaccine intratracheally as a practical alternative to evaluate effects of the vaccine in the deeper lung before conducting an inhalation study prior to the challenge experiments.",
            "startOffset": 30882,
            "title": "Discussion"
        },
        {
            "endOffset": 31508,
            "parents": [],
            "refoffsets": {
                "bib0060": {
                    "endOffset": 31507,
                    "startOffset": 31503
                }
            },
            "secId": "sec0090",
            "sentence": "Recent results with the NP-admixed antigen in a human lung tissue model showed that HAC1/SiO2 was able to re-activate formerly primed T-cells [12].",
            "startOffset": 31361,
            "title": "Discussion"
        },
        {
            "endOffset": 34308,
            "parents": [],
            "refoffsets": {
                "bib0125": {
                    "endOffset": 34307,
                    "startOffset": 34303
                }
            },
            "secId": "sec0090",
            "sentence": "This new protection strategy combines the induction of systemic and local as well as humoral and cellular immune responses [25].",
            "startOffset": 34180,
            "title": "Discussion"
        },
        {
            "endOffset": 24135,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "Cytokines interleukin (IL)-2, interferon-gamma (IFN-\u03b3), IL-5, and IL-10 in the supernatant of re-stimulated PCLS were measured using the murine Th1/Th2 tissue culture kit from Meso Scale Discovery (MSD) Assays (Gaithersburg, MD, USA).",
            "startOffset": 23901,
            "title": "Cytokine measurement"
        },
        {
            "endOffset": 17031,
            "parents": [],
            "refoffsets": {
                "bib0050": {
                    "endOffset": 17030,
                    "startOffset": 17023
                },
                "bib0055": {
                    "endOffset": 17030,
                    "startOffset": 17023
                }
            },
            "secId": "sec0005",
            "sentence": "Other drug delivery systems such as silica nanoparticle (NP) have also been previously shown to have adjuvant properties [10,11].",
            "startOffset": 16902,
            "title": "Introduction"
        },
        {
            "endOffset": 15859,
            "parents": [],
            "refoffsets": {
                "bib0025": {
                    "endOffset": 15858,
                    "startOffset": 15855
                }
            },
            "secId": "sec0005",
            "sentence": "However, it has been described that intranasal antigen administration induces poor immune responses when applied without an appropriate mucosal adjuvant [5].",
            "startOffset": 15702,
            "title": "Introduction"
        },
        {
            "endOffset": 34583,
            "parents": [],
            "secId": "sec0090",
            "sentence": "In this study, the double-adjuvanted vaccine demonstrated the ability to induce systemic functional antibody responses as well as local cellular immune responses suggesting the advantage of combining proper adjuvants and the relevance of immunizing at the site of infection.",
            "startOffset": 34309,
            "title": "Discussion"
        },
        {
            "endOffset": 17298,
            "parents": [],
            "refoffsets": {
                "bib0060": {
                    "endOffset": 17297,
                    "startOffset": 17293
                }
            },
            "secId": "sec0005",
            "sentence": "Recently, we have shown that a combination of a plant-produced recombinant hemagglutinin (HA) antigen from the H1N1 influenza virus A/California/04/09 (HAC1) with silica-NP (SiO2) was able to recall a previously established immune response in human lung tissue [12].",
            "startOffset": 17032,
            "title": "Introduction"
        },
        {
            "endOffset": 23518,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "A Topcount Microplate Scintillation Counter (Canberra-Packard, Dreieich, Germany) measured 3H-thymidine-positive cells as counts per minute.",
            "startOffset": 23378,
            "title": "Splenocyte proliferation assay"
        },
        {
            "endOffset": 28121,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "In order to ensure that the induction of mucosal IgA in the single positive mouse was a result of vaccination, mice were immunized with a higher antigen concentration (10 \u03bcg HAC1) and the BAL was examined for the presence of HAC1-specific IgG and IgA (Fig. 3A and B).",
            "startOffset": 27854,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 23213,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0100": {
                    "endOffset": 23212,
                    "startOffset": 23208
                }
            },
            "secId": "sec0045",
            "sentence": "Isolated splenocytes (1 \u00d7 105 cells) of vaccinated mice were incubated in 96-well round bottom plates with RPMI supplemented with 5% fetal bovine serum, containing 10 \u03bcg/mL HAC1 or PBS (negative control) at 37 \u00b0C for 72 h. Proliferation was measured as described before [20].",
            "startOffset": 22938,
            "title": "Splenocyte proliferation assay"
        },
        {
            "endOffset": 27690,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "HAC1/SiO2 or HAC1/c-di-GMP did not induce detectable IgG or IgA in the BAL of immunized mice.",
            "startOffset": 27597,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 28641,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Mice receiving HAC1/SiO2/c-di-GMP developed enhanced levels of mucosal IgG (540 \u00b1 271) and IgA (490 \u00b1 283) in 100% of vaccinated mice.",
            "startOffset": 28507,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 24969,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Differences between treatment groups and controls were considered statistically significant at p < 0.05.",
            "startOffset": 24865,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 17522,
            "parents": [],
            "refoffsets": {
                "bib0065": {
                    "endOffset": 17521,
                    "startOffset": 17517
                }
            },
            "secId": "sec0005",
            "sentence": "Manufacturing of recombinant proteins in plants for influenza vaccine development evolved as an alternative to the conventional egg-based vaccine production to overcome the limitations in quantity and time consumption [13].",
            "startOffset": 17299,
            "title": "Introduction"
        },
        {
            "endOffset": 33377,
            "parents": [],
            "secId": "sec0090",
            "sentence": "In fact, this study was not designed to compare dose-sparing effects of local versus systemic applications, but rather to evaluate an additive effect of combined adjuvants.",
            "startOffset": 33205,
            "title": "Discussion"
        },
        {
            "endOffset": 22345,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0095": {
                    "endOffset": 22344,
                    "startOffset": 22340
                }
            },
            "secId": "sec0040",
            "sentence": "HA-specific serum IgG antibodies and nasal IgG and IgA were assessed using ELISA assay, as previously described [19].",
            "startOffset": 22228,
            "title": "Antibody measurement"
        },
        {
            "endOffset": 34904,
            "parents": [],
            "refoffsets": {
                "bib0140": {
                    "endOffset": 34903,
                    "startOffset": 34896
                },
                "bib0145": {
                    "endOffset": 34903,
                    "startOffset": 34896
                },
                "bib0150": {
                    "endOffset": 34903,
                    "startOffset": 34896
                }
            },
            "secId": "sec0090",
            "sentence": "Even though a challenge study would be necessary to prove that the local and systemic immune responses observed here can provide protection against influenza virus infection, there is convincing evidence in the literature that the measured immune responses discussed above have been linked to protective efficacy [28\u201330].",
            "startOffset": 34583,
            "title": "Discussion"
        },
        {
            "endOffset": 15489,
            "parents": [],
            "refoffsets": {
                "bib0020": {
                    "endOffset": 15423,
                    "startOffset": 15420
                }
            },
            "secId": "sec0005",
            "sentence": "In 2003 Flumist\u00ae, the first nasal influenza vaccine with live attenuated influenza viruses, has been approved in the US [4], which protects locally at the site of virus entry and infection.",
            "startOffset": 15300,
            "title": "Introduction"
        },
        {
            "endOffset": 18490,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Furthermore, it presented evidence of antigen-primed T-cells in the lung in intratracheally vaccinated mice.",
            "startOffset": 18382,
            "title": "Introduction"
        },
        {
            "endOffset": 30200,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "However, the c-di-GMP-adjuvanted HAC1 antigen induced cells to secret slightly elevated levels of IL-5 upon HAC1 re-stimulation (2.2 \u00b1 0.1 and 2.4 \u00b1 0.1 for single- and double-adjuvanted, respectively) compared to non-stimulated PCLS.",
            "startOffset": 29966,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 24304,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "The assay was performed and results were analyzed according to manufacturer's specifications using MSD plates, MSD Sector Imager 2400, and Discovery workbench software.",
            "startOffset": 24136,
            "title": "Cytokine measurement"
        },
        {
            "endOffset": 16817,
            "parents": [],
            "refoffsets": {
                "bib0045": {
                    "endOffset": 16816,
                    "startOffset": 16813
                }
            },
            "secId": "sec0005",
            "sentence": "Moreover, Svindland et al. tested vaccination with c-di-GMP combined with a second adjuvant, Chitosan, and showed that vaccination with the combination of these molecules can further improve the humoral and cellular immune responses against target antigens [9].",
            "startOffset": 16556,
            "title": "Introduction"
        },
        {
            "endOffset": 31671,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Even though HAC1/SiO2 had a re-activating potential in human PCLS, vaccination of mice intratracheally was barely able to induce seroprotection (HAI titer >1:40).",
            "startOffset": 31509,
            "title": "Discussion"
        },
        {
            "endOffset": 20889,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Mice were immunized on days 0 and 21 with either 5 \u03bcg antigen (HAC1), single- or double-adjuvanted vaccine (5 \u03bcg HAC1/10 \u03bcg SiO2; 5 \u03bcg HAC1/7.5 \u03bcg c-di-GMP; 5 \u03bcg HAC1/10 \u03bcg SiO2/7.5 \u03bcg c-di-GMP) by intratracheal route (50 \u03bcl).",
            "startOffset": 20663,
            "title": "Vaccination and sample collection"
        },
        {
            "endOffset": 30761,
            "parents": [],
            "secId": "sec0090",
            "sentence": "The present study evaluated the systemic and local immunogenicity of a double-adjuvanted influenza vaccine (HAC1/SiO2/c-di-GMP) delivered via the respiratory tract.",
            "startOffset": 30597,
            "title": "Discussion"
        },
        {
            "endOffset": 15701,
            "parents": [],
            "secId": "sec0005",
            "sentence": "An advantage of delivering vaccines via the respiratory route is, besides the inductions of local immune responses at virus settlement, the non-invasive application which is likely to increase public compliance.",
            "startOffset": 15490,
            "title": "Introduction"
        },
        {
            "endOffset": 32085,
            "parents": [],
            "secId": "sec0090",
            "sentence": "However, addition of the mucosal adjuvant c-di-GMP to HAC1/SiO2 induced HAI and IgG antibodies and T-cells that are considered potential markers for systemic and local protective immune responses against influenza infection.",
            "startOffset": 31861,
            "title": "Discussion"
        },
        {
            "endOffset": 25927,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Mice vaccinated with either HAC1/SiO2 or HAC1/c-di-GMP developed low titers of HAI antibodies after the second vaccination (43 \u00b1 30 and 12 \u00b1 7; Fig. 1A), as well as modest serum IgG titers following the booster dose (205 \u00b1 81 and 2980 \u00b1 1419; Fig. 1B).",
            "startOffset": 25675,
            "title": "Intratracheal administration of double-adjuvanted HAC1 with SiO2 and c-di-GMP induced robust systemic antibody responses"
        },
        {
            "endOffset": 37448,
            "parents": [],
            "secId": "sec0090",
            "sentence": "The fold induction of the Th1 cytokines for the double-adjuvanted vaccinated mice, however, far exceeded the level of Th2 cytokines that were induced (IFN-\u03b3:IL-5, about 119-fold; IFN-\u03b3:IL-10, about 39-fold).",
            "startOffset": 37241,
            "title": "Discussion"
        },
        {
            "endOffset": 20175,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 20174,
                    "startOffset": 20170
                }
            },
            "secId": "sec0025",
            "sentence": "The transformed bacterium was introduced into hydroponically grown Nicotiana benthamiana by vacuum infiltration and leaf tissues were harvested, homogenized, extracted, filtered and chromatographically purified after a one-week growing period [14].",
            "startOffset": 19927,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 31860,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Moreover, it did not induce any local immune response, such as antigen-specific Ig secretion or T-cell induction upon re-stimulation, when administered at a lower antigen dose (5 \u03bcg HAC1).",
            "startOffset": 31672,
            "title": "Discussion"
        },
        {
            "endOffset": 33617,
            "parents": [],
            "secId": "sec0090",
            "sentence": "The systemic administration was only used as a control for the vaccination protocol as well as antigen stability and not meant as a comparative group to evaluate superior efficacy of the respiratory vaccination to the systemic vaccination.",
            "startOffset": 33378,
            "title": "Discussion"
        },
        {
            "endOffset": 18750,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Female wild-type BALB/c mice aged 6\u20138 weeks (Charles River, Sulzfeld, Germany) were kept at an animal facility under conventional housing conditions (22 \u00b0C, 55% humidity, 12-h day/night cycle) with food and tap water ad libitum.",
            "startOffset": 18522,
            "title": "Animals"
        },
        {
            "endOffset": 36651,
            "parents": [],
            "secId": "sec0090",
            "sentence": "The induction of Th1 cytokines in re-stimulated PCLS indicates that the antigen was recognized by HAC1-specific memory T-cells.",
            "startOffset": 36524,
            "title": "Discussion"
        },
        {
            "endOffset": 33924,
            "parents": [],
            "refoffsets": {
                "bib0130": {
                    "endOffset": 33923,
                    "startOffset": 33916
                },
                "bib0135": {
                    "endOffset": 33923,
                    "startOffset": 33916
                }
            },
            "secId": "sec0090",
            "sentence": "Also the role of IgA in cross-protection against drifted virus strains has been shown to contribute to protection, albeit it is not essential [26,27].",
            "startOffset": 33774,
            "title": "Discussion"
        },
        {
            "endOffset": 23878,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0050",
            "sentence": "Two PCLS (approx. 300 \u03bcm thick) per well were treated with 10 \u03bcg/mL HAC1 or medium (non-stimulated) and cultured under cell culture conditions (37 \u00b0C, 5% CO2 and 95% air humidity) for 24 h. Supernatant was collected and stored at \u221280 \u00b0C until use.",
            "startOffset": 23631,
            "title": "Antigen stimulation of precision-cut lung slices (PCLS)"
        },
        {
            "endOffset": 35301,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Their results regarding the induction of mucosal IgA, serum IgG and systemic HAI titers after vaccine administration into the lower airways of the lung were in line with the results presented above.",
            "startOffset": 35103,
            "title": "Discussion"
        },
        {
            "endOffset": 26105,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "The group receiving the double-adjuvanted vaccine, HAC1/SiO2/c-di-GMP, developed high HAI titers (770 \u00b1 470; Fig. 1A) and antigen-specific IgG titers (43,840 \u00b1 23,923; Fig. 1B).",
            "startOffset": 25928,
            "title": "Intratracheal administration of double-adjuvanted HAC1 with SiO2 and c-di-GMP induced robust systemic antibody responses"
        },
        {
            "endOffset": 38231,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Overall, the data presented in the current study demonstrate that the double-adjuvanted HAC1 vaccine is immunogenic in the mouse model when administered intratracheally.",
            "startOffset": 38062,
            "title": "Discussion"
        },
        {
            "endOffset": 25294,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "As main readout parameters for a systemic antibody response HAI and HAC1-specific IgG titers were analyzed in the blood of vaccinated mice.",
            "startOffset": 25155,
            "title": "Intratracheal administration of double-adjuvanted HAC1 with SiO2 and c-di-GMP induced robust systemic antibody responses"
        },
        {
            "endOffset": 20241,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Aliquots of purified HAC1 were kept in PBS at \u221280 \u00b0C until usage.",
            "startOffset": 20176,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 21040,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "For intratracheal immunization mice were tilted (\u223c45\u00b0) and the vaccine administered into the deep lung with subsequent insufflation with an air bolus.",
            "startOffset": 20890,
            "title": "Vaccination and sample collection"
        },
        {
            "endOffset": 21207,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "A systemic control group to ensure the effectiveness of the vaccination protocol, received 1 \u03bcg HAC1 adsorbed on aluminum hydroxide (Alum) intraperitoneally (200 \u03bcl).",
            "startOffset": 21041,
            "title": "Vaccination and sample collection"
        },
        {
            "endOffset": 35430,
            "parents": [],
            "secId": "sec0090",
            "sentence": "They detected only in the primed intrapulmonary immunization mucosal sIgA in the lung, but not the intramuscular administration.",
            "startOffset": 35302,
            "title": "Discussion"
        },
        {
            "endOffset": 28370,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "One mouse given HAC1/SiO2 developed mucosal IgG titers above baseline (30 \u00b1 5 vs. 25) while two mice developed detectable IgA (titer 45 \u00b1 15 vs. 25).",
            "startOffset": 28221,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 29110,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "Cytokine secretion upon antigen stimulation was compared to the non-stimulated cytokine baseline level and expressed as fold induction.",
            "startOffset": 28975,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 32603,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Although mucosal IgG and IgA were induced by the single-adjuvanted vaccine HAC1/c-di-GMP, a higher antigen dose was required.",
            "startOffset": 32478,
            "title": "Discussion"
        },
        {
            "endOffset": 36054,
            "parents": [],
            "refoffsets": {
                "bib0040": {
                    "endOffset": 36053,
                    "startOffset": 36048
                },
                "bib0045": {
                    "endOffset": 36053,
                    "startOffset": 36048
                }
            },
            "secId": "sec0090",
            "sentence": "It has been shown previously that intranasal administration of c-di-GMP as an adjuvant for influenza vaccines can induce multifunctional influenza-specific CD4+ Th1 cells in the spleen of immunized mice [8,9].",
            "startOffset": 35845,
            "title": "Discussion"
        },
        {
            "endOffset": 24778,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Statistical analyses were performed by either the Kruskal\u2013Wallis test with Dunn's multiple comparison post hoc tests or by the Mann\u2013Whitney test using GraphPad 4.03 (GraphPad, San Diego, CA, USA).",
            "startOffset": 24582,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 20627,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Immediately prior to immunization, HAC1 was admixed with the adjuvant and/or silica-NP and swirled \u2265 10 min on an overhead shaker to ensure complete mixing.",
            "startOffset": 20471,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 22205,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0085": {
                    "endOffset": 22204,
                    "startOffset": 22197
                },
                "bib0090": {
                    "endOffset": 22204,
                    "startOffset": 22197
                }
            },
            "secId": "sec0035",
            "sentence": "Seroconversion in vaccinated animals was defined as an HAI antibody titer at a serum dilution of \u2265 1:40 [17,18].",
            "startOffset": 22093,
            "title": "HAI assay"
        },
        {
            "endOffset": 29790,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "Additionally, re-stimulation of PCLS from HAC1/SiO2/c-di-GMP vaccinated mice also induced IL-2 and IFN-\u03b3 (262 \u00b1 132-fold and 275 \u00b1 138-fold).",
            "startOffset": 29649,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 14919,
            "parents": [],
            "refoffsets": {
                "bib0005": {
                    "endOffset": 14918,
                    "startOffset": 14915
                }
            },
            "secId": "sec0005",
            "sentence": "Annual influenza-associated cases of hospitalization and up to 500,000 deaths during frequent virus outbreaks and sporadic pandemics illustrate the serious health burden of influenza virus infections [1].",
            "startOffset": 14715,
            "title": "Introduction"
        },
        {
            "endOffset": 23630,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0105": {
                    "endOffset": 23629,
                    "startOffset": 23622
                },
                "bib0110": {
                    "endOffset": 23629,
                    "startOffset": 23622
                }
            },
            "secId": "sec0050",
            "sentence": "Murine PCLS were prepared as described before [21,22].",
            "startOffset": 23576,
            "title": "Antigen stimulation of precision-cut lung slices (PCLS)"
        },
        {
            "endOffset": 35102,
            "parents": [],
            "refoffsets": {
                "bib0145": {
                    "endOffset": 35101,
                    "startOffset": 35097
                }
            },
            "secId": "sec0090",
            "sentence": "For example, Liu et al. compared different routes of immunization and their effect on local and systemic immune responses and combined this with lung protection against an influenza infection [29].",
            "startOffset": 34905,
            "title": "Discussion"
        },
        {
            "endOffset": 21428,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Blood was obtained by retrobulbar sampling and sera were collected on days 0, 21, 35, and 49 to determine HA-specific antibody response by hemagglutination inhibition (HAI) and enzyme-linked immunosorbent (ELISA) assays.",
            "startOffset": 21208,
            "title": "Vaccination and sample collection"
        },
        {
            "endOffset": 26575,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "The cell proliferation level was compared to non-stimulated splenocytes from the same animal.",
            "startOffset": 26482,
            "title": "Addition of c-di-GMP adjuvant was necessary to induce antigen-specific splenocytes"
        },
        {
            "endOffset": 27596,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "In contrast, the positive control group (HAC1-Alum) showed antigen-specific IgG titers in the BAL (115 \u00b1 37) comparable to the double-adjuvanted group, while IgA levels were undetectable.",
            "startOffset": 27409,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 29648,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "Results also showed that in contrast to HAC1/SiO2, re-stimulation with HAC1/c-di-GMP did induce antigen-specific cells producing IL-2 and IFN-\u03b3 (155 \u00b1 60 and 244 \u00b1 118, respectively).",
            "startOffset": 29465,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 18381,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Overall, it showed the potential of the c-di-GMP/SiO2 double-adjuvanted vaccine to induce systemic humoral and strong mucosal immune responses, with IgA in the airways.",
            "startOffset": 18213,
            "title": "Introduction"
        },
        {
            "endOffset": 27854,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "However, addition of c-di-GMP to HAC1/SiO2 did induce detectable levels of IgG in 2/5 mice (115 \u00b1 73; Fig. 3A) and in one mouse detectable levels of IgA (Fig. 3B).",
            "startOffset": 27691,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 18009,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Regarding the need of rapidly produced vaccines in times of pandemics and the time consuming limitation of the egg-based vaccines, the here presented study tested the recombinant antigen of a highly immunogenic H1N1 strain responsible for the 2009/2010 pandemic.",
            "startOffset": 17747,
            "title": "Introduction"
        },
        {
            "endOffset": 36319,
            "parents": [],
            "refoffsets": {
                "bib0155": {
                    "endOffset": 36318,
                    "startOffset": 36311
                },
                "bib0160": {
                    "endOffset": 36318,
                    "startOffset": 36311
                }
            },
            "secId": "sec0090",
            "sentence": "Furthermore, multifunctional Th1 cells have also been shown to be present in the blood of vaccinated human volunteers and in the non-inflamed normal human lung tissue, as determined by their potential to produce IL-2, IFN-\u03b3 and/or TNF-\u03b1 upon re-activation [31,32].",
            "startOffset": 36055,
            "title": "Discussion"
        },
        {
            "endOffset": 26367,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "To further evaluate the systemic immune response following intratracheal vaccination, the proliferation index of splenocytes upon antigenic re-stimulation was assessed (Fig. 2).",
            "startOffset": 26190,
            "title": "Addition of c-di-GMP adjuvant was necessary to induce antigen-specific splenocytes"
        },
        {
            "endOffset": 20427,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0075": {
                    "endOffset": 20426,
                    "startOffset": 20419
                },
                "bib0080": {
                    "endOffset": 20426,
                    "startOffset": 20419
                }
            },
            "secId": "sec0025",
            "sentence": "The production of c-di-GMP has been described before [15,16].",
            "startOffset": 20366,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 24429,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0060": {
                    "endOffset": 24428,
                    "startOffset": 24424
                }
            },
            "secId": "sec0055",
            "sentence": "Total protein concentrations were measured in PCLS lysates using the BCA Protein Assay kit (Pierce, Rockford, IL, USA) [12].",
            "startOffset": 24305,
            "title": "Cytokine measurement"
        },
        {
            "endOffset": 19826,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "The optimized HA sequence contains a 6\u00d7 His affinity purification tag and the ER retention signal KDEL at the C-terminus.",
            "startOffset": 19705,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 21811,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Collected sera were treated with a receptor-destroying enzyme (Denka Seiken, Japan).",
            "startOffset": 21727,
            "title": "HAI assay"
        },
        {
            "endOffset": 32268,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Importantly, no adverse side effects or clinical signs of decreased well-being of the study animals were observed after intratracheal administration of the double-adjuvanted vaccine.",
            "startOffset": 32086,
            "title": "Discussion"
        },
        {
            "endOffset": 18212,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Furthermore, the study extends the published work with HAC1 and SiO2 and evaluates the immunogenicity of this vaccine formulation when combined with c-di-GMP and administered at the site of virus entry.",
            "startOffset": 18010,
            "title": "Introduction"
        },
        {
            "endOffset": 27264,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "Local immune responses in the lung were assessed by measuring HA-specific IgG or IgA titers in BAL samples (Fig. 3A and B).",
            "startOffset": 27141,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 32947,
            "parents": [],
            "secId": "sec0090",
            "sentence": "However, 10 \u03bcg of antigen were required to induce local IgG and IgA in 100% of the vaccinated mice.",
            "startOffset": 32848,
            "title": "Discussion"
        },
        {
            "endOffset": 16901,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Besides its adjuvantive effects, Chitosan is used as an intranasal delivery system.",
            "startOffset": 16818,
            "title": "Introduction"
        },
        {
            "endOffset": 38062,
            "parents": [],
            "secId": "sec0090",
            "sentence": "The fact that the double-adjuvanted vaccine induced IL-10-competent cells might also contribute to a reduced level of inflammation in the lungs with repeated exposure to the virus post vaccination.",
            "startOffset": 37865,
            "title": "Discussion"
        },
        {
            "endOffset": 22689,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Antigen-specific IgG and IgA were detected using horseradish peroxidase-conjugated goat anti-mouse IgG or IgA antibody (Jackson Immunoresearch Laboratories Inc., PA, USA), respectively.",
            "startOffset": 22504,
            "title": "Antibody measurement"
        },
        {
            "endOffset": 24558,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0055",
            "sentence": "Cytokines were correlated to total protein (ng/mg) and compared to the non-stimulated cytokine baseline level as fold induction.",
            "startOffset": 24430,
            "title": "Cytokine measurement"
        },
        {
            "endOffset": 31361,
            "parents": [],
            "refoffsets": {
                "bib0115": {
                    "endOffset": 31360,
                    "startOffset": 31356
                }
            },
            "secId": "sec0090",
            "sentence": "Minne and colleagues described the impact of vaccine delivery site on the immune responses and concluded that targeting the lower lungs for an inhaled influenza vaccination can induce systemic and local immune responses most efficiently [23].",
            "startOffset": 31119,
            "title": "Discussion"
        },
        {
            "endOffset": 25434,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "The non-adjuvanted group vaccinated with HAC1 only did not develop detectable HAI or antigen-specific IgG antibodies in the serum (Fig. 1).",
            "startOffset": 25295,
            "title": "Intratracheal administration of double-adjuvanted HAC1 with SiO2 and c-di-GMP induced robust systemic antibody responses"
        },
        {
            "endOffset": 33773,
            "parents": [],
            "refoffsets": {
                "bib0120": {
                    "endOffset": 33772,
                    "startOffset": 33765
                },
                "bib0125": {
                    "endOffset": 33772,
                    "startOffset": 33765
                }
            },
            "secId": "sec0090",
            "sentence": "The importance of mucosal IgA during influenza infection and its ability to neutralize virus in infected epithelial cells has previously been shown [24,25].",
            "startOffset": 33617,
            "title": "Discussion"
        },
        {
            "endOffset": 36854,
            "parents": [],
            "refoffsets": {
                "bib0160": {
                    "endOffset": 36853,
                    "startOffset": 36849
                }
            },
            "secId": "sec0090",
            "sentence": "These results are in line with the hypothesis by Jul-Larsen and colleagues who discussed that addition of an adjuvant improves the efficacy of HAC1 toward the induction of a robust T-cell response [32].",
            "startOffset": 36652,
            "title": "Discussion"
        },
        {
            "endOffset": 27408,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0080",
            "sentence": "The non-adjuvanted group vaccinated with HAC1 only did not develop detectable IgG or IgA in the BAL (baseline IgG/IgA level 25; Fig. 3A and B).",
            "startOffset": 27265,
            "title": "The double-adjuvanted vaccine induced local IgG and IgA antibody responses in the BAL"
        },
        {
            "endOffset": 20365,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "For silica-NP, DMEM and SiO2 nanopowder (HDK 200, Wacker Chemie, Germany) were mixed and dispersed by ultrasonic sonotrode.",
            "startOffset": 20242,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 25024,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "The number of mice is indicated in the figure legends.",
            "startOffset": 24970,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 21583,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "On day 49, mice were sacrificed with an intraperitoneal overdosing of pentobarbital-Na (Merial, Hallbergmoos, Germany) and cutting the Vena cava inferior.",
            "startOffset": 21429,
            "title": "Vaccination and sample collection"
        },
        {
            "endOffset": 21715,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "BAL fluids, agarose-filled lungs, and spleens were sampled and used for immunoglobulin (Ig) measurements and re-stimulation assays.",
            "startOffset": 21584,
            "title": "Vaccination and sample collection"
        },
        {
            "endOffset": 16087,
            "parents": [],
            "refoffsets": {
                "bib0035": {
                    "endOffset": 16086,
                    "startOffset": 16083
                }
            },
            "secId": "sec0005",
            "sentence": "In 2007, bis-(3\u2032,5\u2032)-cyclic dimeric guanosine monophosphate (c-di-GMP) was introduced as a mucosal adjuvant with promising activity [7].",
            "startOffset": 15951,
            "title": "Introduction"
        },
        {
            "endOffset": 24864,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0060",
            "sentence": "Data were expressed as mean \u00b1 standard error of the mean (SEM) or median \u00b1 quartiles.",
            "startOffset": 24779,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 37063,
            "parents": [],
            "refoffsets": {
                "bib0040": {
                    "endOffset": 37062,
                    "startOffset": 37054
                },
                "bib0045": {
                    "endOffset": 37062,
                    "startOffset": 37054
                },
                "bib0165": {
                    "endOffset": 37062,
                    "startOffset": 37054
                }
            },
            "secId": "sec0090",
            "sentence": "Additionally, our results aligned with previous studies on intranasally administered c-di-GMP showing an induction of a Th1-biased cytokine profile in re-stimulated splenocytes against target antigen [8,9,33].",
            "startOffset": 36854,
            "title": "Discussion"
        },
        {
            "endOffset": 18819,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "The randomized study was approved by a local agency (Application-No.",
            "startOffset": 18751,
            "title": "Animals"
        },
        {
            "endOffset": 30586,
            "parents": [
                {
                    "id": "sec0065",
                    "title": "Results"
                }
            ],
            "secId": "sec0085",
            "sentence": "In contrast, IL-10 levels were enhanced in PCLS samples from HAC1/c-di-GMP as well as HAC1/SiO2/c-di-GMP vaccinated mice, when re-stimulated with HAC1 (12 \u00b1 4 and 7 \u00b1 2, respectively).",
            "startOffset": 30402,
            "title": "Animals immunized with HAC1/SiO2/c-di-GMP showed a T-cell immune response upon antigenic re-stimulation"
        },
        {
            "endOffset": 38630,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Even though the protective efficacy of the double-adjuvanted HAC1 vaccine needs to be evaluated in a relevant animal model, the present study demonstrates that the double-adjuvanted HAC1 induces systemic functional antibody response as well as local humoral and cellular immune responses when administered via the respiratory tract, indicating potential for future needle-free vaccine applications.",
            "startOffset": 38232,
            "title": "Discussion"
        },
        {
            "endOffset": 22092,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "HAI endpoint titers were determined as reciprocal of the highest serum dilution causing complete HAI.",
            "startOffset": 21991,
            "title": "HAI assay"
        },
        {
            "endOffset": 19494,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0070": {
                    "endOffset": 19493,
                    "startOffset": 19489
                }
            },
            "secId": "sec0025",
            "sentence": "HAC1 was produced as previously described [14].",
            "startOffset": 19447,
            "title": "Vaccine and adjuvants"
        },
        {
            "endOffset": 37652,
            "parents": [],
            "secId": "sec0090",
            "sentence": "Nevertheless, the double-adjuvanted vaccine, as well as the c-di-GMP admixed antigen, induced IL-10 secretion in PCLS upon antigenic re-stimulation which exceeded the non-stimulated IL-10 baseline level.",
            "startOffset": 37449,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X14005131",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Vanessa",
                "initial": "V.",
                "last": "Neuhaus"
            },
            {
                "email": null,
                "first": "Jessica A.",
                "initial": "J.A.",
                "last": "Chichester"
            },
            {
                "email": null,
                "first": "Thomas",
                "initial": "T.",
                "last": "Ebensen"
            },
            {
                "email": null,
                "first": "Katharina",
                "initial": "K.",
                "last": "Schwarz"
            },
            {
                "email": null,
                "first": "Caitlin E.",
                "initial": "C.E.",
                "last": "Hartman"
            },
            {
                "email": null,
                "first": "Yoko",
                "initial": "Y.",
                "last": "Shoji"
            },
            {
                "email": null,
                "first": "Carlos A.",
                "initial": "C.A.",
                "last": "Guzm\u00e1n"
            },
            {
                "email": null,
                "first": "Vidadi",
                "initial": "V.",
                "last": "Yusibov"
            },
            {
                "email": null,
                "first": "Katherina",
                "initial": "K.",
                "last": "Sewald"
            },
            {
                "email": "armin.braun@item.fraunhofer.de",
                "first": "Armin",
                "initial": "A.",
                "last": "Braun"
            }
        ],
        "doi": "10.1016/j.vaccine.2014.04.011",
        "firstpage": "3216",
        "issn": "0264410X",
        "keywords": [
            "C-di-GMP",
            "HAC1",
            "Influenza vaccine",
            "Mucosal adjuvant",
            "Plant-based",
            "Silica nanoparticle"
        ],
        "lastpage": "3222",
        "openaccess": "Full",
        "pub_year": 2014,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung"
    }
}